- Home
- MATH vs BYSI Comparison
MATH vs BYSI Comparison
Compare MATH & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- BYSI
- Stock Information
- Founded
- MATH 2015
- BYSI 2010
- Country
- MATH Hong Kong
- BYSI United States
- Employees
- MATH N/A
- BYSI N/A
- Industry
- MATH Finance/Investors Services
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- MATH Finance
- BYSI Health Care
- Exchange
- MATH Nasdaq
- BYSI Nasdaq
- Market Cap
- MATH 60.8M
- BYSI 67.3M
- IPO Year
- MATH N/A
- BYSI 2017
- Fundamental
- Price
- MATH $3.22
- BYSI $1.75
- Analyst Decision
- MATH
- BYSI
- Analyst Count
- MATH 0
- BYSI 0
- Target Price
- MATH N/A
- BYSI N/A
- AVG Volume (30 Days)
- MATH 193.2K
- BYSI 20.0K
- Earning Date
- MATH 01-01-0001
- BYSI 05-12-2025
- Dividend Yield
- MATH N/A
- BYSI N/A
- EPS Growth
- MATH N/A
- BYSI N/A
- EPS
- MATH 0.17
- BYSI N/A
- Revenue
- MATH $31,399,049.00
- BYSI N/A
- Revenue This Year
- MATH N/A
- BYSI N/A
- Revenue Next Year
- MATH N/A
- BYSI N/A
- P/E Ratio
- MATH $19.30
- BYSI N/A
- Revenue Growth
- MATH 291.58
- BYSI N/A
- 52 Week Low
- MATH $0.80
- BYSI $0.98
- 52 Week High
- MATH $3.23
- BYSI $2.97
- Technical
- Relative Strength Index (RSI)
- MATH 74.97
- BYSI 54.76
- Support Level
- MATH $2.79
- BYSI $1.62
- Resistance Level
- MATH $3.08
- BYSI $1.77
- Average True Range (ATR)
- MATH 0.33
- BYSI 0.09
- MACD
- MATH 0.06
- BYSI -0.01
- Stochastic Oscillator
- MATH 99.11
- BYSI 73.53
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.